​I joined Kelly in October 2011 with experience in financial analyses and reporting to top management in pharmaceutical industry.
At Kelly I am responsible for budgeting and prognosis preparation, presenting monthly results, variances and ad-hoc analysis enabling decision making to deliver excellence in execution across key performance indicators.